BioPhero ApS: Financial statements 2020
CVR: 38109340
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
BioPhero ApS (CVR 38109340) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,136,048 and a net result of DKK -3,047,901 compared with DKK -4,721,556 the year before. That is an increase of 210.3% compared with the year before. Equity in the 2020 report amounted to DKK 14,703,251. The solvency ratio was 53%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 5,136,048
- Profit/Loss
- DKK -3,047,901
- Equity
- DKK 14,703,251
- Total Assets
- DKK 27,744,623
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 5.1 mio. | -3 mio. | 14.7 mio. | 14 |
| 2019 | - | 1.7 mio. | -4.7 mio. | 10.3 mio. | 10 |
| 2018 | - | 1.6 mio. | 0 | 3.8 mio. | 3 |
Official annual report
How creditworthy is BioPhero ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BioPhero ApS
BioPhero ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 27 October 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 28 employees (2022). In 2022, the company reported a gross profit of DKK -3,589,565 and a net result of DKK -17,401,517 compared with DKK -14,667,216 the year before. Equity in the 2022 report amounted to DKK 85,098,933.